Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome

Clinical trial NCT03818191 · COMPLETED

Trial details

NCT number: NCT03818191
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2019-07-15
Primary completion: 2023-11-04
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.